Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
6,080.00
+10.00 (0.16%)
At close: Dec 5, 2025
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 145.35 billion as of December 5, 2025. Its market cap has decreased by -19.15% in one year.
Market Cap
145.35B
Enterprise Value
264.84B
Revenue
252.20B
Ranking
n/a
PE Ratio
61.01
Stock Price
6,080.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 145.35B, a decrease of -82.25%. That is a compound annual growth rate of -15.25%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.30T |
| ALTEOGEN | 27.86T |
| ABL Bio | 11.02T |
| SK Biopharmaceuticals | 10.53T |
| Yuhan | 8,955.73B |
| LigaChem Biosciences | 6,907.33B |
| HLB Co., Ltd. | 6,670.96B |